These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 20334632)

  • 1. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    Trials; 2010 Mar; 11():32. PubMed ID: 20334632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    BMC Med; 2010 Mar; 8():18. PubMed ID: 20334633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)].
    Schulz KF; Altman DG; Moher D;
    Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):604-12. PubMed ID: 20619135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Ann Intern Med; 2010 Jun; 152(11):726-32. PubMed ID: 20335313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    J Clin Epidemiol; 2010 Aug; 63(8):834-40. PubMed ID: 20346629
    [No Abstract]   [Full Text] [Related]  

  • 9. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    BMJ; 2010 Mar; 340():c332. PubMed ID: 20332509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Bian ZX; Shang HC
    Ann Intern Med; 2011 Feb; 154(4):290-1; author reply 291-2. PubMed ID: 21320945
    [No Abstract]   [Full Text] [Related]  

  • 11. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Obstet Gynecol; 2010 May; 115(5):1063-1070. PubMed ID: 20410783
    [No Abstract]   [Full Text] [Related]  

  • 12. Have CONSORT guidelines improved the quality of reporting of randomised controlled trials published in public health dentistry journals?
    Savithra P; Nagesh LS
    Oral Health Prev Dent; 2013; 11(2):95-103. PubMed ID: 23534035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trials behind level A recommendations in obstetric practice bulletins: compliance with CONSORT statement.
    Chauhan SP; Berghella V; Sanderson M; Siddiqui D; Hendrix NW; Magann EF
    Am J Perinatol; 2009 Jan; 26(1):69-80. PubMed ID: 18979412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
    Boutron I; Altman DG; Moher D; Schulz KF; Ravaud P;
    Ann Intern Med; 2017 Jul; 167(1):40-47. PubMed ID: 28630973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CONSORT 2010 statement: updated guidelines can improve wound care.
    Weller C; McNeil J
    J Wound Care; 2010 Aug; 19(8):347-53. PubMed ID: 20852507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information on adverse events in randomised clinical trials assessing drug interventions published in four medical journals with high impact factors.
    Maggi CB; Griebeler IH; Dal Pizzol Tda S
    Int J Risk Saf Med; 2014; 26(1):9-22. PubMed ID: 24796347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CONSORT 2010 Declaration: updated guideline for reporting parallel group randomised trials].
    Cobos-Carbó A; Augustovski F
    Med Clin (Barc); 2011 Jul; 137(5):213-5. PubMed ID: 21239025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.